SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001683168-23-001128
Filing Date
2023-02-24
Accepted
2023-02-24 17:15:17
Documents
14
Period of Report
2023-02-24
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K sonoma_8k.htm   iXBRL 8-K 31941
2 AMENDMENT TO AGREEMENT sonoma_ex0101.htm EX-1.1 16303
3 OPINION sonoma_ex0501.htm EX-5.1 11798
  Complete submission text file 0001683168-23-001128.txt   242982

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE snoa-20230224.xsd EX-101.SCH 3239
5 XBRL LABEL FILE snoa-20230224_lab.xml EX-101.LAB 34240
6 XBRL PRESENTATION FILE snoa-20230224_pre.xml EX-101.PRE 22367
8 EXTRACTED XBRL INSTANCE DOCUMENT sonoma_8k_htm.xml XML 3587
Mailing Address 5445 CONESTOGA COURT, SUITE 150 BOULDER CO 80301
Business Address 5445 CONESTOGA COURT, SUITE 150 BOULDER CO 80301 800-759-9305
Sonoma Pharmaceuticals, Inc. (Filer) CIK: 0001367083 (see all company filings)

IRS No.: 680423298 | State of Incorp.: DE | Fiscal Year End: 0331
Type: 8-K | Act: 34 | File No.: 001-33216 | Film No.: 23668649
SIC: 2834 Pharmaceutical Preparations